PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by Adpathway
BeeBright/iStock via Getty Images
Shares of VeriSign (NASDAQ:VRSN) fell about 8% on Friday despite third quarter results and outlook drawing praise from analysts.
Citi reiterated its Buy rating and $337 price target on the shares of VeriSign, which provides internet infrastructure and domain name registry services.
English (US) · 
French (CA) · 
French (FR) ·